Skip to main content
editorial
. 2015 Aug 14;21(30):8994–9001. doi: 10.3748/wjg.v21.i30.8994

Figure 1.

Figure 1

Small interfering RNAs/micro-interfering RNAs delivery. Ideally, the optimal delivery system should be able to discriminate between healthy hepatocytes (brown cells) and hepatocellular carcinoma cells (red cell). In addition, it should be able to protect small interfering RNAs (siRNAs)/micro-interfering RNAs (miRNAs) and favor their cellular uptake. NPs: Nanoparticles loaded with the therapeutic siRNAs/miRNAs.